Javier Escalante's questions to Kenvue Inc (KVUE) leadership • Q2 2025
Question
Javier Escalante questioned the framework for Kenvue's strategic review, drawing a parallel to P&G's history of divesting entire business units and asking specifically about the approach to the lower-profitability Skin Health segment.
Answer
Interim CEO Kirk Perry declined to comment on specific segments within the ongoing strategic review. He emphasized that poor execution has been a significant factor in underperformance and that the team is focused on controllable factors like demand creation through improved consumer insights, brand building, innovation, and go-to-market excellence.